title: Ribavirin trials and hantavirus--what we should not conclude.
authors.forename: Kendall A
authors.initials: KA
authors.lastname: Marcus
authors.forename: Rosemary
authors.initials: R
authors.lastname: Johann-Liang
authors.forename: John H
authors.initials: JH
authors.lastname: Powers
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D018804:Hantavirus Pulmonary Syndrome / Q000188:drug therapy*; D006801:Humans; D015203:Reproducibility of Results; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use*; D018401:Sample Size; D045169:Severe Acute Respiratory Syndrome / Q000188:drug therapy
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin